Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid to prevent anastomotic leak after rectal cancer surgery
ISRCTN13727659Phase 2Active, not recruiting
- Sponsor
- University of Leeds
- Start
- Dec 2024
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial of tranexamic acid in rectal cancer and sigmoid colon cancer (2 arms), sponsored by University of Leeds. Primary endpoints: Number of eligible patients recruited, Average compliance to the study treatment schedule and 4 more. Started Dec 2024; status: active, not recruiting.
02
Drugs
tranexamic acid
03
Conditions
rectal cancersigmoid colon cancer
Beyond the preview
Go deeper on ISRCTN13727659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN13727659.